Verena Wu PhD

Research Fellow, The Daffodil Centre. Working towards equity for immigrants affected by cancer. Views are my own.

[Dr Poorva Pradhan @PoorvaPradhan]

Is #fearofrecurrence all about negatives? Well research says it’s also about exploring #positives: enhanced health awareness, strengthened relationships, resilience and revaluation of life goals.
#IPOS2024

[A/Prof Ben Smith @bensmithphd.bsky.social @cancer_K2A]

An honour to present a clinical pathway for #Cancer #FearofRecurrence at #IPOS2024 on behalf of an awesome team. For anyone who's interested you'll be able to read more in @jcansurv soon! Thanks to @cancerNSW for their support & to all those who contributed to this work #PsyOnc

[Verena Wu PhD @Verena_SW]

@DrAnnaSingleton @DionCandelaria_ @SonaliMunot @SHPartners @AndrewJBaillie @Leanne_Hassett @MitchellSarkies Thanks @DrAnnaSingleton! It was such a great experience 😊

[Verena Wu PhD @Verena_SW]

Yay! I’m very excited to collaborate with @drcarolynee @canrevive @cancer_K2A @POCOG1 @JiaJennyLiu + team on this @SHPartners #impsci pilot grant which will explore the equitable implementation of a #fearofrecurrence clinical pathway among Chinese-speaking #cancersurvivors

[The Daffodil Centre @DaffodilCentre]

🎉CONGRATULATIONS to @Verena_SW who is a recipient of a @SHPartners #ImplementationScience pilot grant!

Learn more about Dr Verena Wu's research at the #DaffodilCentre here🔗 https://t.co/dDOQS6xiZm

Read more about this round of grants🔗 https://t.co/noblkD1Laf

@syd_health | @Sydney_Uni | @CCNewSouthWales

[A/Prof Ben Smith @bensmithphd.bsky.social @cancer_K2A]

@Afaf_Girgis @Verena_SW @UNSWMedicine @swsydUNSW @InghamInstitute Congratulations Dr @Verena_SW! 🎉👏🥂 It’s been a honour being part of your PhD journey along with @Afaf_Girgis Looking forward to seeing what great things you achieve in future 💫

[Verena Wu PhD @Verena_SW]

Thank you so much @Afaf_Girgis and @cancer_K2A for your wonderful support and guidance throughout my PhD! I'm so happy we got to celebrate together with my family. Looking forward to the next chapter.

[Afaf Girgis AM (she/her) @Afaf_Girgis]

Very proud supervisor moment for @cancer_K2A & me, celebrating Dr @Verena_SW’s PhD graduation with her family! Congratulations Verena!!! 👏🏼🎉🍾 @UNSWMedicine @swsydUNSW @InghamInstitute

[Verena Wu PhD @Verena_SW]

@Afaf_Girgis @cancer_K2A 😂🙈

[POCOG @POCOG1]

Are you an #OzOnc #HCP? help us develop a consensus clinical pathway for fear of cancer recurrence - scan #QRcode below or click the link:
https://t.co/auDOxCndeR
#FCR #PsyOnc #SuppOnc @COSAoncology @CancerAustralia @cancerNSW @CNSA_ORG @CancerCouncilOz

[UNSW South West Sydney Clinical Campuses @swsydUNSW]

UNSW researchers collaborating with @POCOG1 are seeking expert consensus on a proposed clinical pathway for fear of cancer recurrence - more information and sign up available at https://t.co/DXkxTUgf5d (HC230052 V1, 20/3/23)

[A/Prof Ben Smith @bensmithphd.bsky.social @cancer_K2A]

11/12 the low % of men given a QPL may have been b/c urologists had to get study consent before giving out the QPL OR worry the QPL would:
⬆️ men’s anxiety❌
adversely affect the doctor-patient dynamic ❌
push men towards one treatment ❌
It didn't!
https://t.co/N8hBPr8ncQ
#PCSM

[A/Prof Ben Smith @bensmithphd.bsky.social @cancer_K2A]

10/12 We found:
👍 acceptability: men with #prostatecancer were generally satisfied with the QPL & found it to be a useful tool to guide their consultations with the urologist
👎 feasibility: only 18% of eligible men were given a QPL
https://t.co/N8hBPr8ncQ
#PCSM

[A/Prof Ben Smith @bensmithphd.bsky.social @cancer_K2A]

9/12 We conducted a pilot study looking at QPL:
🔷 acceptability (survey & interview responses regarding QPL satisfaction & usefulness)
🔷 feasibility (% of eligible men given the QPL) https://t.co/N8hBPr8ncQ
#PCSM

[Verena Wu PhD @Verena_SW]

Thanks @cancerNSW for their support of this #telehealth #implementation #systematicreview through their funding of the @ImplementSciCoP. Thanks to Stella Bu as well!

[Verena Wu PhD @Verena_SW]

We've seen a rapid rise in the use of #telehealth in oncology since the COVID-19 pandemic. What does research show about its implementation & barriers/ enablers? We examined #implementation using the #REAIM framework in a #SystematicReview: https://t.co/EDfFxzmTfm @usansomdaly

[Verena Wu PhD @Verena_SW]

What are the implications for further #telehealth #implementation & practice? We need:
🟡Sufficient support for pts & healthcare professionals
🟡 Improved training & infrastructure
🟡 Better access to reliable internet & electronic devices

[A/Prof Ben Smith @bensmithphd.bsky.social @cancer_K2A]

1/9 More than half of all #CancerSurvivors (43+ million 🗺️) report #cancer #FearofRecurrence (#FCR) https://t.co/xktsBAzNTQ
#iConquerFear is feasible & potentially efficacious online #selfhelp program that could address FCR at scale #survonc
NEW 📰👇 https://t.co/QIkh5fYShS
🧵👇

[A/Prof Ben Smith @bensmithphd.bsky.social @cancer_K2A]

Congrats to 🌟 #PhD student @Verena_SW whose 1st PhD 📰, a #SysRev of unmet supportive care needs in #Chinese #cancer patients & caregivers (https://t.co/61K1hbRC2s), is a #TopCitedArticle in @WileyNews Euro Journal of #CancerCare #ProudSupervisor with @Afaf_Girgis